Press Releases - G1 Therapeutics, Inc.

Press Releases

Date	Title
6/13/19	G1 Therapeutics Announces Updates to Board of Directors
6/11/19	G1 Therapeutics to Present at Raymond James Life Sciences and MedTech Conference
6/1/19	G1 Therapeutics Presents Additional Phase 2 Data on Trilaciclib in Small Cell Lung Cancer at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
5/16/19	G1 Therapeutics to Present Additional Trilaciclib Phase 2 Small Cell Lung Cancer Data at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
5/13/19	G1 Therapeutics to Present at UBS Global Healthcare Conference
5/9/19	G1 Therapeutics Provides First Quarter 2019 Corporate and Financial Update
5/2/19	G1 Therapeutics to Report First Quarter Financial Results on May 9, 2019
4/29/19	G1 Therapeutics Announces Positive Feedback from Trilaciclib End-of-Phase 2 Meeting with FDA; Expects to File NDA in 2020
4/2/19	G1 Therapeutics to Present at the 18th Annual Needham Healthcare Conference
3/4/19	G1 Therapeutics to Present at Cowen and Company 39th Annual Healthcare Conference